Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation … J Bousquet, HJ Schünemann, A Togias, C Bachert, M Erhola, PW Hellings, ... Journal of Allergy and Clinical Immunology 145 (1), 70-80. e3, 2020 | 440 | 2020 |
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ... Allergy 70 (11), 1372-1392, 2015 | 308 | 2015 |
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The lancet respiratory medicine 7 (1), 46-59, 2019 | 291 | 2019 |
ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ... Clinical and translational allergy 6 (1), 47, 2016 | 235 | 2016 |
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis J Bousquet, HJ Schünemann, PW Hellings, S Arnavielhe, C Bachert, ... Journal of Allergy and Clinical Immunology 138 (2), 367-374. e2, 2016 | 222 | 2016 |
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis–a EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement PW Hellings, WJ Fokkens, C Bachert, CA Akdis, T Bieber, I Agache, ... Allergy 72 (9), 1297-1305, 2017 | 191 | 2017 |
MASK 2017: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma multimorbidity using real‐world‐evidence J Bousquet, S Arnavielhe, A Bedbrook, M Bewick, D Laune, ... Clinical and translational allergy 8 (1), 45, 2018 | 171 | 2018 |
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology J Bousquet, PW Hellings, I Agache, F Amat, I Annesi-Maesano, ... Journal of Allergy and Clinical Immunology 143 (3), 864-879, 2019 | 166 | 2019 |
Is diet partly responsible for differences in COVID‐19 death rates between and within countries? J Bousquet, JM Anto, G Iaccarino, W Czarlewski, T Haahtela, A Anto, ... Clinical and translational allergy 10 (1), 16, 2020 | 165 | 2020 |
Treatment of allergic rhinitis using mobile technology with real‐world data: the MASK observational pilot study J Bousquet, P Devillier, S Arnavielhe, A Bedbrook, G Alexis‐Alexandre, ... Allergy 73 (9), 1763-1774, 2018 | 155 | 2018 |
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study A Bédard, X Basagana, JM Anto, J Garcia-Aymerich, P Devillier, ... Journal of Allergy and Clinical Immunology 144 (1), 135-143. e6, 2019 | 137 | 2019 |
Next‐generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases JJ Bousquet, HJ Schünemann, A Togias, M Erhola, PW Hellings, ... Clinical and translational allergy 9 (1), 44, 2019 | 132 | 2019 |
Guidance to 2018 good practice: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma J Bousquet, A Bedbrook, W Czarlewski, GL Onorato, S Arnavielhe, ... Clinical and translational allergy 9 (1), 16, 2019 | 131 | 2019 |
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: the MASK study J Bousquet, S Arnavielhe, A Bedbrook, J Fonseca, M Morais Almeida, ... Allergy 73 (2), 505-510, 2018 | 131 | 2018 |
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 130 | 2021 |
Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults E Kurt, S Metintas, I Basyigit, I Bulut, E Coskun, S Dabak, F Deveci, ... European Respiratory Journal 33 (4), 724-733, 2009 | 128 | 2009 |
Prevalence and risk factors of allergies in Turkey: results of a multicentric cross‐sectional study in children E Kurt, S Metintas, I Basyigit, I Bulut, E Coskun, S Dabak, F Deveci, ... Pediatric allergy and immunology 18 (7), 566-574, 2007 | 127 | 2007 |
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study ME Wechsler, A Menzies-Gow, CE Brightling, P Kuna, S Korn, T Welte, ... The Lancet Respiratory Medicine 10 (7), 650-660, 2022 | 126 | 2022 |
Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study J Bousquet, P Devillier, JM Anto, M Bewick, T Haahtela, S Arnavielhe, ... Allergy 73 (8), 1622-1631, 2018 | 109 | 2018 |
Asthma insights and reality in Turkey (AIRET) study BE Sekerel, B Gemicioglu, JB Soriano Respiratory medicine 100 (10), 1850-1854, 2006 | 108 | 2006 |